CSIMarket


Gilead Sciences Inc   (GILD)
Other Ticker:  
 


 

Gilead Sciences Inc

GILD's Financial Statements and Analysis



Gilead Sciences Inc reported in III. Quarter net earnings per share of $2.05 an increase by 606.9 % year on year from $0.29 and an improvement of 69.42 % from $1.21 realized in II. Quarter (Jun 30 2021).


III. Quarter
Earnings Per Share Revenues
$ 2.05 $  7,421 Mill
$+1.76     +606.9 % $+844M     +12.83 %



Gilead Sciences Inc 's Revenue rose by 12.83 % in III. Quarter (Sep 30 2021) year on year, to $7,421 million and advanced by 19.37 % sequentially.


Gilead Sciences Inc is Expected to report next financial results on February 24, 2022.

More on GILD's Income Statement





       
  • Viread 3.94% Y/Y,
• Truvada 5.26% Y/Y,
• Emtriva 22.55% Y/Y,
• HIV products Total 18.47% Y/Y,
• AmBisome 8.66% Y/Y,
• Other products 461.95% Y/Y,
• Letairis 21.62% Y/Y,
• Ranexa 15.62% Y/Y,
• Complera Eviplera 22.55% Y/Y,
• Stribild 65.85% Y/Y
   
     
       
  • Atripla -10.19% Y/Y,
• Sovaldi -62.91% Y/Y
   
     


GILD's Segments

Gilead Sciences Inc 's net income of $2,586 million in III. Quarter increased by 632.58 % from net earnings of $353 million achieved in III. Quarter a year ago.

Sequentially net earnings grew by 70.47 % from net income of $1,517.00 million realized in previous quarter.

More on GILD's Growth

Inventories grew by 66.27 % to $1,676 million from III. Quarter a year ago, sequentially inventories fell by -5.42 %. In III. Quarter company's net cash and cash equivalents decreased by $-531 million, capital expenditures grew by -10.32%, to $-139 millions compare to same quarter a year ago and fell by 16.81% from II. Quarter (Jun 30 2021).

More on GILD's Cash flow Statement


Gilead Sciences Inc payed out dividend of $2.83 per share in last 52 weeks representing 48.29 % of net earning per share in trailing twelve-month period.

During the same period Gilead Sciences Inc earned $ 8.00 cash per share, on a free-cash flow basis 136.51 % of net earning per share.

Book value grew by 8.76 % sequentially to $17.01 per share, 53.95% of net income per share in trailing twelve-month period were contributed to shareholder value.
Tangible Book value grew to $ -16.45 per share from $ -18.23.

Company issued 2.00 million shares or 0.16 % in III. Quarter.
Interest Coverage Ratio was 10.06. Debt Coverage Ratio was 0.35.

More on GILD's Dividends

 Market Capitalization (Millions) 88,012
 Shares Outstanding (Millions) 1,262
 Total Debt (Millions $) 27,686
 Revenue (TTM) (Millions $) 27,482
 Net Income (TTM) (Millions $) 7,369
 Cash Flow (TTM) (Millions $) -8,524
 Capital Exp. (TTM) (Millions $) -604
 Dividend TTM ($) 2.83 $
 Dividend Yield TTM (%) 4.09 %
 Employees (TTM) $ 11,800




Gilead Sciences Inc payed out dividend of $2.83 per share in last 52 weeks representing 48.29 % of net earning per share in trailing twelve-month period.

During the same period Gilead Sciences Inc earned $ 8.00 cash per share, on a free-cash flow basis 136.51 % of net earning per share.

Book value grew by 8.76 % sequentially to $17.01 per share, 53.95% of net income per share in trailing twelve-month period were contributed to shareholder value.
Tangible Book value grew to $ -16.45 per share from $ -18.23.

Company issued 2.00 million shares or 0.16 % in III. Quarter.
Interest Coverage Ratio was 10.06. Debt Coverage Ratio was 0.35.

More on GILD's Balance Sheets

 Market Capitalization (Millions) 88,012
 Shares Outstanding (Millions) 1,262
 Total Debt (Millions $) 27,686
 Revenue (TTM) (Millions $) 27,482
 Net Income (TTM) (Millions $) 7,369
 Cash Flow (TTM) (Millions $) -8,524
 Capital Exp. (TTM) (Millions $) -604
 Dividend TTM ($) 2.83 $
 Dividend Yield TTM (%) 4.09 %
 Employees (TTM) $ 11,800


   



       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

IMII's Profile

Stock Price

IMII's Financials

Business Description

Fundamentals

Charts & Quotes

IMII's News

Suppliers

IMII's Competitors

Customers & Markets

Economic Indicators

IMII's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071